CareDx, Inc

NASDAQ:CDNA

Medical - Diagnostics & Research

Healthcare
$74.44 +5.07%

+$1.19 today

Market cap
$3.91B
Beta
2.48
P/E (TTM)
-154.0
EPS (TTM)
-$0.16
52W Low $10.96High $24.96

Volume 0.54M

Average 0.74M

CDNA Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

CareDx, IncNASDAQ: CDNA

Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026

Cash & equivalents rises 447.8% from a year ago

Cash & equivalents stood at $373.64M at the end of Q2 FY2026, up 447.8% from a year earlier and up 379.5% from the prior quarter. Over 3 fiscal years it compounded at -10.1% a year.

Context

  • Cash & equivalents amounted to 70.1% of total assets at the end of Q2 FY2026, up 54.7 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +447.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$373.64M+379.5% QoQ
Last fiscal yearDec 2025
$65.43M-43.0% YoY
Year agoJun 2025
$68.21M+447.8% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+447.8%——
1 year-43.0%——
3-year CAGR-10.1%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
65.43M USD
Year-over-year change
-43.0%
4-year CAGR
-34.2%

Cash & Equivalents vs competitors

How CDNA compares with its peers on the latest reported figures

  • CDNA's Jun 2026 cash & equivalents of $373.64M is the 4th highest of the 8 companies compared; the peer median is $299.52M.
  • Its year-over-year change of +447.8% is the highest of 8, against a peer median of +9.1%.
  • Cash & equivalents amounts to 70.1% of total assets for CDNA, versus a peer median of 18.5%.
CDNA Competitors Peer median
Cash & Equivalents for CDNA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NTRANatera, Inc.Jun 2026$1.09B +9.1%+32.2%41.1%
QGENQiagen N.V.Jun 2026$768.5M +4.7%+4.7%13.0%
BLLNBillionToOne, Inc.Jun 2026$548.63M +190.3%—75.2%
CDNACareDx, IncJun 2026$373.64M +447.8%-10.1%70.1%
VCYTVeracyte, Inc.Jun 2026$299.52M +36.5%+33.0%20.2%
MYGNMyriad Genetics, Inc.Mar 2026$124.4M +35.5%+38.0%18.5%
WGSGeneDx Holdings Corp.Jun 2026$60.32M -18.6%-8.6%12.5%
FLGTFulgent Genetics, Inc.Mar 2026$23.4M -65.2%-14.2%2.0%
Peer median (excluding CDNA) $299.52M+9.1%+18.4%18.5%

Competitors are the stored peer set for CDNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents348.49M89.92M82.2M114.69M65.43M
Short-term Investments0203.17M153.22M145.96M111.78M
Net Receivables59.76M66.31M51.06M64.61M42.63M
Inventory17.19M19.23M19.47M19.5M26.71M
Other Current Assets09.22M7.76M7.07M10.59M
Total Current Assets433.36M387.85M313.71M351.83M257.13M
Property, Plant & Equipment (Net)40.04M70.22M65.14M57.89M55.73M
Goodwill36.98M37.52M40.34M40.34M40.34M
Intangible Assets50.2M43.05M45.7M38.18M31.96M
Long-term Investments000024.17M
Tax Assets00000
Other Non-current Assets6.05M4.35M1.94M2.81M3.9M
Total Non-current Assets133.26M155.14M153.11M139.22M156.1M
Total Assets566.62M542.99M466.83M491.05M413.23M
Account Payables13.34M9.94M12.87M7.69M9.99M
Short-term Debt00000
Tax Payables00000
Deferred Revenue4.21M5.34M4.75M4.85M4.65M
Other Current Liabilities32.77M21.31M26.24M41.12M41.61M
Total Current Liabilities77.3M75.98M78.07M89.37M89.85M
Long-term Debt00000
Deferred Tax Liabilities415K0136K164K181K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities5.64M2.7M99.01M819K418K
Total Non-current Liabilities23.44M36.11M127.43M23.25M20.28M
Total Liabilities100.75M112.08M205.5M112.62M110.13M
Common Stock52K52K49K51K50K
Retained Earnings(383.19M)(460.44M)(678.27M)(626.24M)(735.36M)
Accumulated OCI(4.67M)(7.5M)(6.96M)(8.57M)(5.52M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity465.88M430.91M261.33M378.43M303.1M
Total Debt21.35M39M34.22M28.37M26.19M
Net Debt(327.13M)(50.92M)(47.98M)(86.32M)(39.24M)

CareDx, Inc

NASDAQ:CDNA

Intrinsic Alpha fair value

Locked

Current Price

$74.44

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.